Hülya Çiçek

Prof. Hülya Çiçek

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2007 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HÇHülya Çiçek
Hülya Çiçek
SBSibel Bayil
Sibel Bayil
YZYasemin Zer
Yasemin Zer
ACAhmet Celik
Ahmet Celik
IGIclal Geyikli
Iclal Geyikli

20 January 2017 in Turkish Journal of Biochemistry
Verified
Journal Article
Closed access
HÇHülya Çiçek
Hülya Çiçek
NGNesli Güleken
Nesli Güleken
SÖSerdar Öztuzcu
Serdar Öztuzcu
ASAlper Sevinç
Alper Sevinç
Objective: Certain cancer types have been shown to be associated with vitamin D deficiency. The aim of this study was to appraise the relationship between the vitamin D receptor (VDR) gene single nucleotide polymorphisms (SNPs) of VDR Fok1 and Bsm1 with serum vitamin D, calcium and phosphorus levels among patients of lung, colon, breast and pancreatic cancer patients. Materials and methods: Groups; lung, colon, breast and pancreatic cancer patients (n=212) and 58 age-matched healthy controls. Serum levels of vitamin D were measured by immunochemiluminesence method and Fok1 and Bsm1 genotypes were assessed with Real-Time Polymerase Chain Reaction. Results: VDR Fok1 and Bsm1 genetic polymorphisms have a significant difference between lung cancer and control group subjects (p=0.042, p=0.040, respectively). VDR Bsm1 genetic polymorphism has a significant association between breast cancer and control group according to the logistic regression model (p=0.038). Vitamin D levels were found significantly lower in all cancer groups (p<0.01). Phosphorus levels of lung cancer and calcium levels of pancreatic cancer patients were statistically significantly lower than control group (p<0.02, p<0.01). Conclusion: This study indicates that VDR genetic polymorphisms, calcium, phosphorus and vitamin D status of individuals were associated with certain cancer species.

30 December 2022 in Journal of Chemistry and Nutritional Biochemistry
Verified
Journal Article
Open access
PDF file
HÇHülya Çiçek
Hülya Çiçek
HKHanim Seval Kaya
Hanim Seval Kaya
CKCemile Kilic
Cemile Kilic
MSMuslum Savas
Muslum Savas
SRSubramanian Ravichandran
Subramanian Ravichandran
Except for one tropical African species, the Rosa L. species (roses; Rosoideae: Rosaceae) has 150–200 species that are extensively dispersed throughout temperate and subtropical ecosystems of the northern hemisphere. The fact that Central Asia is the rose's native continent is underlined in numerous sources. A quarter of the rose species are found in Europe and North America, while nearly half are found in Asia. Rosa damascene Mill is the species utilized to obtain rose oil, even though there are 24 types of roses registered in Turkey's flora. Rosa damascene, also referred to as the Damascus Rose, Pink Oil Rose, Oil Rose, and Isparta Rose Rose is a perennial, thorny, intensely perfumed, pink-hued, half-layered, and winter-hardy shrub that only blooms in the spring. The range of products is also increasing due to the demand for roses and rose products in this sector. Many products are being developed in the field of nutrition, cleaning, and cosmetics. The aim of this study is to investigate the effects of wild rose plants in the field of health and to expand their use. However, it is thought that increasing the variety of products obtained from the wild rose plant may contribute to the country's economy. The aim of the study is to investigate the use of wild rose plant in our country and in other countries, to show in which diseases it is used and to determine its contribution to the economy of the countries.

25 September 2019 in Journal of Oncological Sciences
Verified
Journal Article
Open access
PDF file
HÇHülya Çiçek
Hülya Çiçek
ÖSÖzlem Saygılı
Özlem Saygılı
ÖSÖzlem Nuray Sever
Özlem Nuray Sever
VKVildan Kaya
Vildan Kaya
HUHasan Ulusal
Hasan Ulusal
MYMustafa Yıldırım
Mustafa Yıldırım
Aim: Despite the improved diagnosis and treatment methods in recent years, the number of new breast cancer cases does not reduce and the mortality rates are still so high. There are several proteins that play significant roles in carcinogenesis process and hold a great potential to be used as a marker of cancer diagnosis. A-Kinase Anchoring Protein 12 (AKAP12) regulates gene expression in cell cycle and apoptosis while B- cell Lymphoma 2 (BCL2) family proteins and inhibitors of apoptosis proteins are the major regulators of the apoptotic process. High mobility group box 1 (HMGB1) has multiple pro-tumor roles in tumor development. In our study, we aimed to determine the usability and sensitivity of AKAP12, BCL2 and HMGB1 proteins as a marker of breast cancer diagnosis, and further investigate the relationship among these proteins. Material and Methods Between 2014 and 2017, a total number of 82 participants, 60 of them were diagnosed with early stage breast cancer and 22 healthy age-matched people as control group, were included in the study. Serum samples obtained from the groups were investigated in terms of AKAP12, BCL2 and HMGB1 levels by using Enzyme Linked Immuno-Sorbent Assay (ELISA) method. Results: Comparing the patient group with control groups, AKAP12, BCL2 and HMGB1 levels were found to be significantly higher in the patient group (p = 0.009), (p < 0.001) and (p < 0.001), respectively. Conclusion: The findings of our results indicate that these proteins levels may be used as markers in the diagnosis and follow-up of breast cancer.

1 December 2020 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
BUBerna Kaya Ugur
Berna Kaya Ugur
HÇHülya Çiçek
Hülya Çiçek
SKSeval Kul
Seval Kul
AMAyse Ozlem Mete
Ayse Ozlem Mete
MYMehmet Yılmaz
Mehmet Yılmaz

28 December 2022 in Medeniyet Medical Journal
Verified
Journal Article
Open access
BBBurak Bilgin
Burak Bilgin
MGMete Guler
Mete Guler
HÇHülya Çiçek
Hülya Çiçek
SUSelma Urfalioglu
Selma Urfalioglu
GKGokhan Kokusari
Gokhan Kokusari
BSBedia Marangozoglu Sahin
Bedia Marangozoglu Sahin
Diabetic retinopathy is a common diabetic microvascular problem. Its diagnosis and classification are based on visible changes in clinical fundus examination. However, the discovery of possible vitreous biomarkers in patients with proliferative and nonproliferative diabetic retinopathy may guide both the differentiation and degree of retinopathy. Biomarkers that will be accepted can be also a treatment target. Amphiregulin (AREG) promotes proliferative and regenerative activity and repairs most cell types by binding and activating epidermal growth factor receptors. Progranulin (PGRN) has complex functions in many physiological and pathological processes. Thus, this study aimed to report vitreous AREG and PGRN levels in patients with diabetes and proliferative retinopathy and compare the results with those without diabetes. Thirty-three eyes of 33 patients with proliferative diabetic retinopathy and 31 eyes of 31 patients without diabetes were included in this study. Vitreous humor samples were collected from all patients at the time of pars plana vitrectomy surgery immediately before the surgical procedure. Vitreous AREG and PGRN values were determined by the ELISA method. The mean AREG and PGRN values were similar in the groups (p=0.427, p=0.459, respectively). The results demonstrated that vitreous AREG and PGRN levels have no significant relationship with proliferative diabetic retinopathy.